CD19 and acute lymphoblastic leukemia: In a different analysis of 83 patients treated with axi-cel, tisa-cel, and the CD19-28z CAR T-cell therapy for ALL, within the first week, hemoglobin nadir was 7.1 g/dl, platelets were 29.5 × 103/μL, ANC was 0, and WBC was 0.2 × 103/μL [18].